Bioporto AS (LTS:0JJM) 3-Year Revenue Growth Rate : -7.60% (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Bioporto AS 3-Year Revenue Growth Rate?

Bioporto AS's Revenue per Share for the three months ended in Jun. 2024 was kr0.02.

During the past 12 months, Bioporto AS's average Revenue per Share Growth Rate was -2.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was -7.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was -10.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was -5.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Bioporto AS was 18.70% per year. The lowest was -21.40% per year. And the median was -2.75% per year.

Competitive Comparison of Bioporto AS's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Bioporto AS's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioporto AS's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioporto AS's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Bioporto AS's 3-Year Revenue Growth Rate falls into.

Bioporto AS 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Bioporto AS (LTS:0JJM) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Bioporto AS 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Bioporto AS's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioporto AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioporto AS (LTS:0JJM) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

THOXF:USA BIOPOR:Denmark 2P4:Germany

Address

Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900

Website

https://www.bioporto.com

Bioporto A/S is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.

Bioporto AS Headlines

No Headlines